With exponential growth potential and a continually evolving marketplace, it is vital that pharmaceutical businesses adapt to maximize efficiency and secure their continued growth and development for the long term.
To compete in today’s market, many pharmaceutical businesses are streamlining their operations and focusing their growth in highly targeted areas. Contract Development and Manufacturing Organizations (CDMOs) are experiencing a boom within the pharmaceutical industry, with many firms reporting annual growth in the double digits.
We have extensive experience in helping our clients build core divisions through M&A activity. PharmaBioSource clients benefit from our long-standing relationships across the industry and a team of expert consultants, who apply first-hand sector knowledge to consistently create the best solutions and outcomes.
With decades of experience and intimate sector knowledge, the PharmaBioSource team advises on:
- Sourcing Manufacturing Facilities
- Sale, Lease and Purchase of Pilot Plant and Manufacturing Facilities
- Carve Outs and Divestments
- Corporate M&A Transactions
- Investment Diligence
- Manufacturing Capacity Evaluation
- CMO and CDMO Research, Evaluation, and Sourcing
Our Mission & Values
To provide our clients with insightful analysis, actionable advice, timely support and access to emerging life science opportunities.
PharmaBioSource was born when our founder and CEO, William (Bill) Wiederseim was engaged with two other specialty consulting firms to…